Long-term endocrine therapy adherence remains low after breast cancer surgery
Many patients with early-stage breast cancer do not consistently maintain the long-term hormone therapy prescribed after lumpectomy, a large U.S. insurance claims analysis indicates.
Read original article on The Medical News →Related news
-
Low-dose radiation shows lasting benefits in patients with knee osteoarthritis
United Kingdom
-
Why one gut microbe is attracting attention in heart failure research
United Kingdom
-
Hypofractionated radiotherapy for prostate cancer matches conventional treatment outcomes
United Kingdom
-
Gut bacteria signature may predict type 2 diabetes risk
United Kingdom
-
Two-molecule blood test accurately identifies infections in febrile infants
United Kingdom
-
Could the Mediterranean diet protect the brain through the gut?
United Kingdom
-
Heated tobacco users had more hypertension, but the story is not that simple
United Kingdom
-
New digital tool helps doctors map critical brain functions during tumor removal
United Kingdom